GB0715949D0 - Peptide with improved solubility - Google Patents

Peptide with improved solubility

Info

Publication number
GB0715949D0
GB0715949D0 GB0715949A GB0715949A GB0715949D0 GB 0715949 D0 GB0715949 D0 GB 0715949D0 GB 0715949 A GB0715949 A GB 0715949A GB 0715949 A GB0715949 A GB 0715949A GB 0715949 D0 GB0715949 D0 GB 0715949D0
Authority
GB
United Kingdom
Prior art keywords
peptide
improved solubility
solubility
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0715949A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Circassia Ltd
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Priority to GB0715949A priority Critical patent/GB0715949D0/en
Publication of GB0715949D0 publication Critical patent/GB0715949D0/en
Priority to ES08750553T priority patent/ES2425486T3/en
Priority to EP08750553.3A priority patent/EP2156183B1/en
Priority to PCT/GB2008/001614 priority patent/WO2008139163A1/en
Priority to US12/599,264 priority patent/US20110038881A1/en
Priority to PL08788348T priority patent/PL2083856T3/en
Priority to KR1020107005503A priority patent/KR101699554B1/en
Priority to ES08788348T priority patent/ES2353362T3/en
Priority to PCT/GB2008/002779 priority patent/WO2009022155A2/en
Priority to EA201070271A priority patent/EA023303B1/en
Priority to EA201070270A priority patent/EA018110B1/en
Priority to NZ583362A priority patent/NZ583362A/en
Priority to MX2010001779A priority patent/MX2010001779A/en
Priority to US12/673,334 priority patent/US8551493B2/en
Priority to DE602008002810T priority patent/DE602008002810D1/en
Priority to EP08788347A priority patent/EP2190473B1/en
Priority to CN2008801116120A priority patent/CN101820907B/en
Priority to JP2010520628A priority patent/JP5697447B2/en
Priority to AU2008288283A priority patent/AU2008288283B2/en
Priority to PT111781811T priority patent/PT2397154E/en
Priority to PCT/GB2008/002781 priority patent/WO2009022157A2/en
Priority to DK08788347.6T priority patent/DK2190473T3/en
Priority to US12/673,386 priority patent/US9340580B2/en
Priority to EP08788348A priority patent/EP2083856B1/en
Priority to ES08788347T priority patent/ES2402956T3/en
Priority to PCT/GB2008/002780 priority patent/WO2009022156A2/en
Priority to US12/673,412 priority patent/US8652485B2/en
Priority to AT08788348T priority patent/ATE482721T1/en
Priority to BRPI0815395-7A2A priority patent/BRPI0815395A2/en
Priority to DK08788348.4T priority patent/DK2083856T3/en
Priority to PT08788348T priority patent/PT2083856E/en
Priority to EP11178181.1A priority patent/EP2397154B1/en
Priority to EP10006685A priority patent/EP2286833A3/en
Priority to PCT/GB2008/002778 priority patent/WO2009022154A2/en
Priority to SI200830933T priority patent/SI2190473T1/en
Priority to CA2696563A priority patent/CA2696563A1/en
Priority to NZ583361A priority patent/NZ583361A/en
Priority to SI200830119T priority patent/SI2083856T1/en
Priority to CN201310140326.XA priority patent/CN103272227B/en
Priority to HK09112173.5A priority patent/HK1132194A1/en
Priority to ZA2010/01056A priority patent/ZA201001056B/en
Priority to ZA2010/01054A priority patent/ZA201001054B/en
Priority to IL203943A priority patent/IL203943A/en
Priority to HR20100662T priority patent/HRP20100662T1/en
Priority to CY20101101127T priority patent/CY1110981T1/en
Priority to HK12105353.6A priority patent/HK1164700A1/en
Priority to HRP20130270AT priority patent/HRP20130270T1/en
Priority to US13/974,603 priority patent/US20130336999A1/en
Priority to US14/150,045 priority patent/US20140186403A1/en
Priority to JP2014204979A priority patent/JP6040207B2/en
Priority to CY20151100901T priority patent/CY1116828T1/en
Priority to US15/095,480 priority patent/US20160289281A1/en
Priority to JP2016191563A priority patent/JP2017061455A/en
Priority to US15/294,973 priority patent/US9744222B2/en
Ceased legal-status Critical Current

Links

GB0715949A 2007-05-09 2007-08-15 Peptide with improved solubility Ceased GB0715949D0 (en)

Priority Applications (54)

Application Number Priority Date Filing Date Title
GB0715949A GB0715949D0 (en) 2007-08-15 2007-08-15 Peptide with improved solubility
ES08750553T ES2425486T3 (en) 2007-05-09 2008-05-09 Prognosis analysis to determine the response of T cells to HLA antigens and their use in the field of tissue transplantation
EP08750553.3A EP2156183B1 (en) 2007-05-09 2008-05-09 Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
PCT/GB2008/001614 WO2008139163A1 (en) 2007-05-09 2008-05-09 Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
US12/599,264 US20110038881A1 (en) 2007-05-09 2008-05-09 Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
PL08788348T PL2083856T3 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
KR1020107005503A KR101699554B1 (en) 2007-08-15 2008-08-15 Peptides for vaccine
ES08788348T ES2353362T3 (en) 2007-08-15 2008-08-15 PEPTIDES FOR INSENSITIZATION AGAINST ALLERGENS.
PCT/GB2008/002779 WO2009022155A2 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
EA201070271A EA023303B1 (en) 2007-08-15 2008-08-15 Peptide composition for tolerization to house dust mites and use thereof
EA201070270A EA018110B1 (en) 2007-08-15 2008-08-15 Peptides with reduced dimer formation
NZ583362A NZ583362A (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
MX2010001779A MX2010001779A (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens.
US12/673,334 US8551493B2 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
DE602008002810T DE602008002810D1 (en) 2007-08-15 2008-08-15 PEPTIDES FOR DESENSIBILIZING AGAINST ALLERGENIC
EP08788347A EP2190473B1 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
CN2008801116120A CN101820907B (en) 2007-08-15 2008-08-15 Peptide with multiple epitopes
JP2010520628A JP5697447B2 (en) 2007-08-15 2008-08-15 Peptides for desensitization to allergens
AU2008288283A AU2008288283B2 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
PT111781811T PT2397154E (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
PCT/GB2008/002781 WO2009022157A2 (en) 2007-08-15 2008-08-15 Peptide with improved solubility
DK08788347.6T DK2190473T3 (en) 2007-08-15 2008-08-15 PEPTID WITH REDUCED DIMERING
US12/673,386 US9340580B2 (en) 2007-08-15 2008-08-15 Peptide with multiple epitopes
EP08788348A EP2083856B1 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
ES08788347T ES2402956T3 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
PCT/GB2008/002780 WO2009022156A2 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
US12/673,412 US8652485B2 (en) 2007-08-15 2008-08-15 Peptide for vaccine
AT08788348T ATE482721T1 (en) 2007-08-15 2008-08-15 PEPTIDES FOR DESENSITIZATION TO ALLERGENS
BRPI0815395-7A2A BRPI0815395A2 (en) 2007-08-15 2008-08-15 COMPOSITION, VECTOR, PRODUCT, PHARMACEUTICAL FORMULATION, IN VITRO METHOD TO DETERMINE IF T-CELLS RECOGNIZE A POLYPEPTIDE, AND IN VITRO METHOD TO DETERMINE IF AN INDIVIDUAL IS OR IS AT RISK.
DK08788348.4T DK2083856T3 (en) 2007-08-15 2008-08-15 Peptides for desensitization to allergens
PT08788348T PT2083856E (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
EP11178181.1A EP2397154B1 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
EP10006685A EP2286833A3 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
PCT/GB2008/002778 WO2009022154A2 (en) 2007-08-15 2008-08-15 Peptide with multiple epitopes
SI200830933T SI2190473T1 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
CA2696563A CA2696563A1 (en) 2007-08-15 2008-08-15 Peptides for vaccine
NZ583361A NZ583361A (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
SI200830119T SI2083856T1 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
CN201310140326.XA CN103272227B (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
HK09112173.5A HK1132194A1 (en) 2007-08-15 2009-12-24 Peptides for desensibilization against allergens
ZA2010/01056A ZA201001056B (en) 2007-08-15 2010-02-12 Peptides for desensibilization against allergens
ZA2010/01054A ZA201001054B (en) 2007-08-15 2010-02-12 Peptide with reduced dimer formation
IL203943A IL203943A (en) 2007-08-15 2010-02-14 Composition comprising peptide for preventing or treating allergy to house dust mite
HR20100662T HRP20100662T1 (en) 2007-08-15 2010-12-01 Peptides for desensibilization against allergens
CY20101101127T CY1110981T1 (en) 2007-08-15 2010-12-07 DESCRIPTION DESCRIPTION AGAINST ALLERGYOGENES
HK12105353.6A HK1164700A1 (en) 2007-08-15 2012-06-01 Peptides for desensibilization against allergens
HRP20130270AT HRP20130270T1 (en) 2007-08-15 2013-03-25 Peptide with reduced dimer formation
US13/974,603 US20130336999A1 (en) 2007-08-15 2013-08-23 Peptide with reduced dimer formation
US14/150,045 US20140186403A1 (en) 2007-08-15 2014-01-08 Peptide for vaccine
JP2014204979A JP6040207B2 (en) 2007-08-15 2014-10-03 Peptides for desensitization to allergens
CY20151100901T CY1116828T1 (en) 2007-08-15 2015-10-07 PATIENTS FOR DESCRIPTION FROM ALLERGIANS
US15/095,480 US20160289281A1 (en) 2007-08-15 2016-04-11 Peptide with multiple epitopes
JP2016191563A JP2017061455A (en) 2007-08-15 2016-09-29 Peptides for desensitization to allergen
US15/294,973 US9744222B2 (en) 2007-08-15 2016-10-17 Peptide for vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0715949A GB0715949D0 (en) 2007-08-15 2007-08-15 Peptide with improved solubility

Publications (1)

Publication Number Publication Date
GB0715949D0 true GB0715949D0 (en) 2007-09-26

Family

ID=38566457

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0715949A Ceased GB0715949D0 (en) 2007-05-09 2007-08-15 Peptide with improved solubility

Country Status (2)

Country Link
ES (1) ES2353362T3 (en)
GB (1) GB0715949D0 (en)

Also Published As

Publication number Publication date
ES2353362T3 (en) 2011-03-01

Similar Documents

Publication Publication Date Title
EP2150906A4 (en) Zone-associated objects
EP2017283A4 (en) Peptide
GB0817502D0 (en) Orientation detection arrangement
ZA201000283B (en) Reinigung pegylierter polypeptide
GB0723712D0 (en) Peptides
GB0920981D0 (en) Peptides
EP2123666A4 (en) Peptide
EP2036918A4 (en) Peptide derivative
GB0723387D0 (en) Improved dehumldifier
GB0618748D0 (en) Peptide
GB0719231D0 (en) Protein
HK1152717A1 (en) Angiogenic peptide
GB0703945D0 (en) Peptide
EP2370100A4 (en) Peptide adjuvants
EP2188305A4 (en) Modified peptides having toxin-enhancing effects
GB0605774D0 (en) Peptide
GB0708529D0 (en) Peptide standards
GB0920987D0 (en) Peptides
IL197675A0 (en) Peptides
EP2134587A4 (en) Draglink arrangement
GB0715949D0 (en) Peptide with improved solubility
GB0817978D0 (en) Peptides
GB0705115D0 (en) Peptides
GB0705251D0 (en) Peptides
GB0707626D0 (en) Peptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)